Rein Therapeutics, Inc. (RNTX) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Rein Therapeutics Inc is a biopharmaceutical company that focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications. They are headquartered in Austin, Texas.
No case yet. It builds on the next filing, report or 13F period.
RNTX (Rein Therapeutics, Inc.) has 4 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
tall tick = annual report · 1 on record
Rein Therapeutics, Inc. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 2834, Pharmaceutical Preparations, from each company's own filings. Largest first.
Rein Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
High 0.81 at 10:30 am ET, low 0.79 at 10:00 am ET.
58 managers report a position worth $42.3M between them, and 11 of them hold 80% of it.